By MARTHA MENDOZA and JULIET LINDERMAN Associated Press
When precious vats of COVID-19 vaccine are finally ready, the ability to jab the lifesaving solution into the arms of Americans will require hundreds of millions of injections. As part of its strategy to administer the vaccine as quickly as possible, the Trump administration has agreed to invest more than half a billion in tax dollars in ApiJect Systems America, a young company. Its injector is not approved by federal health authorities and the company hasn’t yet set up a factory to manufacture the unapproved devices. The commitment to ApiJect dwarfs the other needle orders the government has placed with a major manufacturer and two other small companies.